Solid Biosciences LLC (SLDB) — Capital Reinvestment Ratio
Latest as of December 2020:
0.05x
Solid Biosciences LLC (SLDB) has a Capital Reinvestment Ratio of 0.05x as of December 2020, meaning it reinvests 0% of its operating cash flow ($1.31 Million) in capital expenditures ($60.00K). See SLDB equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$1.31 Million
USD
Capital Expenditures
$60.00K
USD
Data as of
Dec 2020
Most recent filing
Annual Capital Reinvestment Ratio for Solid Biosciences LLC (None–None)
Year-by-year Capital Reinvestment Ratio for Solid Biosciences LLC from None to None. For live market cap and broader valuation context, see market cap of Solid Biosciences LLC.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow